June 17, 2021   USA
childrenwithdiabetes.com: GAD-Alum Immunotherapy: An Interview with Diamyd Medical’s Ulf Hannelius

Clinical Director Marissa Town at Children With Diabetes interviews CEO Ulf Hannelius about Diamyd Medical's GAD-Alum Immunotherapy research and what it means for the diabetes community.

Read the interview here

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research